Focus on SARS-CoV-2 RNA Modification as a New Therapeutic Approach

  • Funded by National Research Foundation of Korea (NRF), Swedish Research Council
  • Total publications:1 publications

Grant number: 2020-06311

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $180,000
  • Funder

    National Research Foundation of Korea (NRF), Swedish Research Council
  • Principal Investigator

    Tanmoy Mondal
  • Research Location

    Sweden
  • Lead Research Institution

    University of Gothenburg
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Microbiology, Cell and Molecular Biology

Publicationslinked via Europe PMC

Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants.